Allspring Global Investments Holdings LLC acquired a new position in shares of Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 489,075 shares of the company’s stock, valued at approximately $7,487,000. […]
Russell Investments Group Ltd. boosted its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) by 48.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 50,871 shares of the company’s stock after acquiring an additional 16,648 shares during the quarter. […]
State of Alaska Department of Revenue decreased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) by 5.5% in the 4th quarter, Holdings Channel.com reports. The fund owned 13,731 shares of the company’s stock after selling 795 shares during the period. State of Alaska Department of Revenue’s holdings in Neurocrine Biosciences were worth $1,169,000 […]
First Hawaiian Bank acquired a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 8,793 shares of the company’s stock, valued at approximately $749,000. Other large investors also recently modified their holdings […]